DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

« Back to Dashboard

All Clinical Trials for Abacavir Sulfate; Lamivudine; Zidovudine

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00078247	Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis	Completed	Makerere University	Phase 3	2004-10-01	This study is designed to determine whether 6 months of anti-HIV drugs given along with tuberculosis treatment will delay the onset of AIDS in HIV infected African patients.
NCT00078247	Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3	2004-10-01	This study is designed to determine whether 6 months of anti-HIV drugs given along with tuberculosis treatment will delay the onset of AIDS in HIV infected African patients.
NCT00084149	Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	2004-02-01	Cyclosporine A (CsA) is a common long-term treatment used to inhibit the immune response in transplant patients who receive donor organs. CsA may also help people with HIV. The purpose of this study is to determine the safety of and immune response to CsA when given with abacavir sulfate, lamivudine, and zidovudine (ABC/3TC/AZT) and lopinavir/ritonavir (LPV/r) to HIV infected adults in the early stages of infection. Study hypothesis: The combination of CsA and LPV/r given to acutely infected individuals will result in lower levels of proviral DNA and latent infectious virus at 48 weeks compared to acute infected individuals treated with LPV/r alone.

Clinical Trial Conditions for Abacavir Sulfate; Lamivudine; Zidovudine

Condition Name

Condition Name for Abacavir Sulfate; Lamivudine; Zidovudine
Intervention	Trials
HIV Infections	5
HIV Infection	1
Tuberculosis	1

Condition MeSH

Condition MeSH for Abacavir Sulfate; Lamivudine; Zidovudine
Intervention	Trials
HIV Infections	6
Infection	2
Communicable Diseases	2

Clinical Trial Locations for Abacavir Sulfate; Lamivudine; Zidovudine

Trials by Country

Trials by Country for Abacavir Sulfate; Lamivudine; Zidovudine
Location	Trials
United States	29
Canada	5
Mexico	4
Netherlands	1
Spain	1

Trials by US State

Trials by US State for Abacavir Sulfate; Lamivudine; Zidovudine
Location	Trials
New York	3
Illinois	2
Ohio	2
North Carolina	2
Kentucky	1

Clinical Trial Progress for Abacavir Sulfate; Lamivudine; Zidovudine

Clinical Trial Phase

Clinical Trial Phase for Abacavir Sulfate; Lamivudine; Zidovudine
Clinical Trial Phase	Trials
Phase 3	3
Phase 2	3

Clinical Trial Status

Clinical Trial Status for Abacavir Sulfate; Lamivudine; Zidovudine
Clinical Trial Phase	Trials
Completed	6

Clinical Trial Sponsors for Abacavir Sulfate; Lamivudine; Zidovudine

Sponsor Name

Sponsor Name for Abacavir Sulfate; Lamivudine; Zidovudine
Sponsor	Trials
National Institute of Allergy and Infectious Diseases (NIAID)	5
Gilead Sciences	1
Harvard School of Public Health	1

Sponsor Type

Sponsor Type for Abacavir Sulfate; Lamivudine; Zidovudine
Sponsor	Trials
NIH	6
Other	2
Industry	1